Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Food-Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer

NCT01469429 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT01469429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01469429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Food-Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Phase 1/2
Overall status
Completed
Start date
September 4, 2007
Completion date
September 17, 2014
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic squamous neck cancer with occult primary squamous cell carcinoma, paranasal sinus and nasal cavity squamous cell carcinoma, salivary gland squamous cell carcinoma, stage 0 hypopharyngeal cancer, stage 0 laryngeal cancer, stage 0 lip and oral cavity cancer, stage 0 nasopharyngeal cancer, stage 0 oropharyngeal cancer, stage 0 paranasal sinus and nasal cavity cancer, stage i salivary gland cancer, stage i squamous cell carcinoma of the hypopharynx, stage i squamous cell carcinoma of the larynx, stage i squamous cell carcinoma of the lip and oral cavity, stage i squamous cell carcinoma of the nasopharynx, stage i squamous cell carcinoma of the oropharynx, stage i squamous cell carcinoma of the paranasal sinus and nasal cavity, stage i verrucous carcinoma of the larynx, stage i verrucous carcinoma of the oral cavity, stage ii salivary gland cancer, stage ii squamous cell carcinoma of the hypopharynx, stage ii squamous cell carcinoma of the larynx, stage ii squamous cell carcinoma of the lip and oral cavity, stage ii squamous cell carcinoma of the nasopharynx, stage ii squamous cell carcinoma of the oropharynx, stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity, stage ii verrucous carcinoma of the larynx, stage ii verrucous carcinoma of the oral cavity, stage iii salivary gland cancer, stage iii squamous cell carcinoma of the hypopharynx, stage iii squamous cell carcinoma of the larynx, stage iii squamous cell carcinoma of the lip and oral cavity, stage iii squamous cell carcinoma of the nasopharynx, stage iii squamous cell carcinoma of the oropharynx, stage iii verrucous carcinoma of the larynx, stage iii verrucous carcinoma of the oral cavity, stage iv squamous cell carcinoma of the hypopharynx, stage iv squamous cell carcinoma of the nasopharynx, stage iva nasal cavity and paranasal sinus cancer, stage iva oral cavity squamous cell carcinoma, stage iva salivary gland cancer, stage iva squamous cell carcinoma of the larynx, stage iva squamous cell carcinoma of the oropharynx, stage iva verrucous carcinoma of the larynx, stage iva verrucous carcinoma of the oral cavity, stage ivb oral cavity squamous cell carcinoma, stage ivb salivary gland cancer, stage ivb squamous cell carcinoma of the larynx, stage ivb squamous cell carcinoma of the lip and oral cavity, stage ivb squamous cell carcinoma of the oropharynx, stage ivb verrucous carcinoma of the larynx, stage ivb verrucous carcinoma of the oral cavity, stage ivc oral cavity squamous cell carcinoma, stage ivc salivary gland cancer, stage ivc squamous cell carcinoma of the larynx, stage ivc squamous cell carcinoma of the oropharynx, stage ivc verrucous carcinoma of the larynx, stage ivc verrucous carcinoma of the oral cavity, tongue cancer